TY  - GEN
AU  - Valteau-Couanet,Dominique
AU  - Le Deley,Marie-Cécile
AU  - Bergeron,Christophe
AU  - Ducassou,Stéphane
AU  - Michon,Jean
AU  - Rubie,Hervé
AU  - Le Teuff,Gwenael
AU  - Coze,Carole
AU  - Plantaz,Dominique
AU  - Sirvent,Nicolas
AU  - Bouzy,Jeanine
AU  - Chastagner,Pascal
AU  - Hartmann,Olivier
TI  - Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy
SN  - 1545-5017
PY  - 2014///0604
KW  - Abdominal Neoplasms
KW  - drug therapy
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Busulfan
KW  - administration & dosage
KW  - Child
KW  - Child, Preschool
KW  - Combined Modality Therapy
KW  - Consolidation Chemotherapy
KW  - Disease-Free Survival
KW  - Follow-Up Studies
KW  - Gene Amplification
KW  - Genes, myc
KW  - Hematopoietic Stem Cell Transplantation
KW  - Hepatic Veno-Occlusive Disease
KW  - chemically induced
KW  - Humans
KW  - Infant
KW  - Kaplan-Meier Estimate
KW  - Melphalan
KW  - Myeloablative Agonists
KW  - therapeutic use
KW  - Neuroblastoma
KW  - Proportional Hazards Models
KW  - Remission Induction
KW  - Thoracic Neoplasms
KW  - Transplantation Conditioning
KW  - Transplantation, Autologous
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/pbc.24713
ER  -